Wall Street Analysts Believe HOOKIPA Pharma (HOOK) Could Rally 634.38%: Here's is How to Trade

Core Viewpoint - HOOKIPA Pharma Inc. (HOOK) has seen a 0.6% increase in share price over the past four weeks, closing at $5.12, with Wall Street analysts suggesting a potential upside of 634.4% based on a mean price target of $37.60 [1] Price Targets - The average price target consists of five estimates ranging from a low of $15 to a high of $60, with a standard deviation of $18.61, indicating variability among analysts [2] - The lowest estimate suggests a 193% increase from the current price, while the highest indicates a 1071.9% upside [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about HOOK's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which historically correlate with stock price movements [4][9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 25.7%, with one estimate increasing and no negative revisions [10] Zacks Rank - HOOK currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11]